Background: The recommendations in guidelines are based on evidence; however, there is a gap between recommendations and clinical practice.
Objective: To describe the practice of prescribing evidence-based treatments for patients with acute coronary syndrome in Brazil.
Methods: This study carried out a subanalysis of the ACCEPT registry, assessing epidemiological data and the prescription rate of acetylsalicylic acid, p2y12 inhibitors, antithrombotic drugs, beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers (IAT1RB), and statins.